✦ LIBER ✦

Evidence that a gabaergic mechanism influences the development of obesity in obese zucker rats

✍ Scribed by F., Squadrito; Sturniolo, R.; Arcadi, F.; Arcoraci, V.; Caputi, A.P.

Book ID: 114076032
Publisher: Elsevier Science
Year: 1988
Weight: 77 KB
Volume: 20
Category: Article
ISSN: 0031-6989
DOI: 10.1016/s0031-6989(88)80739-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evidence that a GABAergic mechanism infl

Evidence that a GABAergic mechanism influences the development of DOCA-salt hypertension in the rat

✍ Domenicantonio Rotiroti; Benito Palella; Elena Losi; Giuseppe Nistico; Achille P 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Development of a Sleeve Gastrectomy Weig

Development of a Sleeve Gastrectomy Weight Loss Model in Obese Zucker Rats

✍ Peter P. Lopez; Susannah E. Nicholson; Gabriel E. Burkhardt; Robert A. Johnson; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 505 KB

Effects of dietary carbohydrate on the d

Effects of dietary carbohydrate on the development of obesity in heterozygous Zucker rats

✍ Kristin L Morris; Thomas C Namey; Michael B Zemel 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Obese zucker rat: Potential role of intr

Obese zucker rat: Potential role of intraglomerular proteolytic enzymes in the development of glomerulosclerosis

✍ M. Teschner; L. Paczek; R. M. Schaefer; A. Heidland 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 461 KB

Anorectic effect of metformin in obese Z

Anorectic effect of metformin in obese Zucker rats: lack of evidence for the involvement of neuropeptide Y

✍ Juha Rouru; Ullamari Pesonen; Markku Koulu; Risto Huupponen; Eriika Santti; Kirs 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 807 KB

Influence of lovastatin on the pharmacok

Influence of lovastatin on the pharmacokinetics, toxicity and immunologic response of cyclosporine in the obese zucker rat

✍ Kurt L. Berens; Kiumars Vadiei; Lane J. Brunner; Kishor M. Wasan; Dr. David R. L 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

## Abstract The combined use of lovastatin, a hypolipidemic agent effective in the reduction of cholesterol levels, and the lipophilic immunosuppressant, cyclosporine, was studied in the obese rat model. Pharmacokinetics, immunosuppressive activity, lipid levels, and creatinine clearances were comp